 Endoscopic injection sclerotherapy conservative treatment patients unresectable hepatocellular carcinoma esophageal varices endoscopic injection sclerotherapy EIS treatment patients esophageal varices due unresectable hepatocellular carcinoma HCC results HCC patients EIS period majority groups weeks treatment groups significant difference fatal bleeding vs EIS patients index hemorrhage absence portal vein thrombosis EIS risk fatal bleeding mean days survival range EIS group range group EIS temporary control acute esophageal variceal bleeding patients unresectable HCC major factors EIS failure lethal propensity underlying disease portal vein thrombosis